Skip to content

Glaukos GKOS Total debt

Total debt at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$3.06B+15.6%
Exelixis logo
ExelixisEXEL
$169.54M-9.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Calculated from Glaukos’s reported figures.

Plus components not separately reported this period.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's total debt?
Glaukos (GKOS) reported total debt of $105.87M in Q1 2026.
How has Glaukos's total debt changed year-over-year?
Glaukos's total debt decreased by 1.7% year-over-year, from $107.67M to $105.87M.
What is the long-term trend for Glaukos's total debt?
Over 5 years (2020 to 2025), Glaukos's total debt has grown at a 5.2% compound annual growth rate (CAGR), from $82.58M to $106.55M.
What does total debt mean?
The total amount of money a company owes to banks, bondholders, and lessors.
How do you interpret total debt?
An increase suggests higher financial leverage and potential interest expense burden, while a decrease indicates deleveraging or debt repayment. High levels relative to equity or cash flow may signal increased financial risk, particularly in rising interest rate environments.
How does total debt compare across companies?
Peer companies in the medical technology sector typically maintain debt levels aligned with their growth stage and cash flow generation, with mature companies often carrying more debt to optimize capital structure compared to earlier-stage R&D-focused firms.